YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. entered a deal to produce Gilead Sciences Inc.’s remdesivir drug at a plant in McPherson, Kansas.
There's been a shortage of remdesivir after the Food and Drug Administration gave emergency authorization for its use as treatment for COVID-19 patients.
Financial terms of the multiyear deal were not disclosed.
Read more from the Kansas City Business Journal.
Organizers hope to bolster client traffic to center city businesses.
AI expert gives advice at SBJ's People You Need to Know
European-style Christmas market to make debut in Branson next week
Big Cedar Lodge golf courses place on Golfweek list
Original, historic Pipkin building up for sale
Pizza Hut co-founder Dan Carney dies
Annual downtown holiday events combine for Nov. 21 celebration